On Thursday, Wyndham Worldwide Corporation (NYSE:WYN)’s shares inclined 0.40% to $80.40.
Wyndham Hotel Group is set to expand its presence in South Korea by more than 200 percent over the next three years thanks to the signings of 12 new property franchise agreements so far in 2015, counting agreements for three Howard Johnson® hotels, marking the brand’s entry into South Korea.
This year’s signings build upon another 14 franchise agreements in South Korea executed by Wyndham Hotel Group in 2014, bringing the company’s pipeline in the country to more than 7,550 rooms within 26 new-construction hotels under the Ramada®, Days Inn® and Howard Johnson brand flags. Presently, Wyndham Hotel Group has 13 properties and more than 2,800 rooms open and operating in the country.
Wyndham Worldwide Corporation provides hospitality services and products to individual consumers and business customers worldwide. It operates three in segments: Lodging, Vacation Exchange, and Rentals, and Vacation Ownership. The Lodging segment franchises hotels in the upscale, upper midscale, midscale, economy, and extended stay segments, in addition to provides property administration services for full-service and select limited-service hotels. As of February 4, 2015, the company had about 7,440 franchised hotels and 638,300 hotel rooms.
InterOil Corporation (USA) (NYSE:IOC)’s shares dropped -5.26% to $41.28.
InterOil Corporation (USA) (IOC) has resumed drilling at Wahoo with the Wahoo-1 side-track exploration well in Petroleum Prospecting License 474 in the Gulf Province of Papua New Guinea.
Wahoo-1 side-track well is the follow-up to Wahoo-1 which was suspended in July 2014 due to higher-than-predictable pressures.
The Wahoo-1 side-track is a noteworthy step-out from existing gas fields and will test whether the successful trends identified around PRL15 extend 170km to the south-east of Elk Antelope.
InterOil holds a 78.1114% interest in the well and is operator. The remaining 21.8886% interest is held by minority interests. InterOil will keep the market informed of material developments.
InterOil Corporation, an independent oil and gas company, engages in the exploration, appraisal, and development of hydrocarbon structures in Papua New Guinea. Its assets comprise the Elk, Antelope, Raptor, and Bobcat fields comprising exploration licenses covering an area of about 16,000 square kilometers located in the Gulf Province of Papua New Guinea.
At the end of Thursday’s trade, BG Medicine, Inc. (NASDAQ:BGMD)‘s shares dipped -37.23% to $0.929.
BG Medicine, Inc., (BGMD) the developer of the BGM Galectin-3(R) Test, recently declared the pricing of an underwritten public offering of its equity securities. Roth Capital Partners is acting as sole manager for the offering.
The company is offering 2,315,654 Series A units, each comprising of one share of common stock and one half of a warrant to purchase one share of common stock, at a purchase price of $1.00 per Series A unit. The company is also offering 184,346 Series B units, in lieu of Series A units, at a purchase price of $1.00 per Series B unit to those purchasers whose purchase of additional Series A units in the offering would result in the purchaser beneficially owning more than 9.99% of the company’s outstanding common stock following the completion of the offering. Each Series B unit comprises of one fully pre-funded warrant to purchase one share of common stock and one half of a warrant to purchase one share of common stock. The warrants (other than the fully pre-funded warrants) will have an exercise price of $1.00 per share. After the underwriting discount and estimated offering expenses payable by the company, the company anticipates to receive net proceeds of about $2.1 million. There is no established public trading market for the pre-funded warrants or the warrants and the company does not expect a market for these securities to develop. The offering is predictable to close on August 18, 2015, subject to customary closing conditions.
BG Medicine, Inc., a commercial stage company, engages in developing and commercializing diagnostic products used to guide the patients suffering from heart failure and related disorders.
TETRA Technologies, Inc. (NYSE:TTI), ended its Thursday’s trading session with 1.23% gain, and closed at $7.43.
TETRA Technologies, Inc. (TTI) declared second quarter 2015 earnings per share of $0.16, not taking into account Maritech and other charges, which compares to earnings of $0.10 per share in the second quarter of 2014, also not taking into account Maritech and other charges. Second quarter 2015 revenue not taking into account Maritech of $315.9 million raised 31% from the second quarter of 2014 primarily as a result of the acquisition of Compressor Systems, Inc. (“CSI”) on August 4, 2014 by CSI Compressco LP.
Merged GAAP second quarter 2015 earnings per share attributable to TETRA stockholders counting Maritech and other charges were earnings of $0.19, which compares to a loss of $(0.03) in the second quarter of 2014.
Highlights comprise:
- Record second quarter 2015 revenue, adjusted EBITDA, and operating income for the Fluids Division (adjusted EBITDA is a non-GAAP financial measure that is reconciled to the nearest GAAP measure in Plan F).
- Second quarter free cash flow of $43 million(1), not taking into account the impact of $4 million of Maritech asset retirement obligation expenditures.
- A $38 million reduction in TETRA net debt(2) contrast to the end of the first quarter of 2015, and an improvement in debt leverage ratio to 2.38x(3), marking the third successive quarter of debt improvements.
- The successful launch and completion of the first commercial application of our heavy zinc-free completion fluid.
TETRA Technologies, Inc., together with its auxiliaries, operates as a diversified oil and gas services company. It operates through four divisions: Fluids, Production Testing, Compression, and Offshore. The Fluids division manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States, in addition to in Latin America, Europe, Asia, the Middle East, and Africa. This segment also markets liquid and dry calcium chloride products; and provides water administration services for oil and gas operators in North America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.